StockMarketWatch
Trump touts economic wins in battleground states — like a $54 billion Alaskan pipeline — as the midterms draw closer
President Donald Trump is spending time this week talking up big job-creating projects in battleground states.
News
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
StockMarketWatch
Former NFL players are nearly four times as likely to die with brain damage. Is it time to boycott football?
New research says the problem is worse than we thought.
StockMarketWatch
The U.S. economy is defying gravity. Here’s all the good news.
Wall Street just got a health check on the U.S. economy — and almost all the news was positive.
StockMarketWatch
Gold is supposed to be a safe haven when inflation surges. So why isn’t it working that way now?
Every investor knows the drill: When markets buckle, buy gold. But in September, that playbook hasn’t worked as expected.
StockMarketWatch
Wall Street may be sleeping on this networking stock tied to Google and OpenAI
A critical bottleneck in data centers is creating a massive runway for networking stocks like Celestica, according to Bernstein.
StockMarketWatch
Saving your retirement could come down to this simple writing exercise
A “retirement policy statement” lays out instructions that you can stick to.
StockMarketWatch
A tough job market is pushing more young Americans to make a big bet: on themselves
There has been a rise in entrepreneurship among young Americans as the entry-level labor market has become tougher to join.
StockMarketWatch
The 15 worst-performing S&P 500 stocks during a dismal September
The S&P 500 has gained slightly in September, but three-quarters of its components have declined.
StockMarketWatch
Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.
StockCNBC Finance
Kalshi, Polymarket trading volumes on some products raises questions amid massive growth
Unusual trading patterns on Kalshi and Polymarket are drawing scrutiny as experts debate whether reported volumes reflect organic market activity.
StockMarketWatch
This is the big risk that stock investors should be watching as rising bond yields menace markets
While investors worry a spike in global bond yields will drag U.S. equities into correction territory, strategists at BofA Global Research say the real threat lies elsewhere.
StockMarketWatch
Major car rivals are teaming up to solve the biggest EV roadblock: Reliable charging
A coalition of carmakers says that in nine months, it has doubled the number of charging ports it offers — although its network size still pales in comparison to Tesla’s.
StockMarketWatch
How Amazon’s stock can fight off the AI threat and soar 46%
Some investors worry that AI agents pose a risk to Amazon, but a Rosenblatt analyst thinks the company “can navigate this period of transition largely unaffected.”
StockMarketWatch
Americans get back to their spending ways. Economy might be speeding up again.
Consumer spending snapped back in August after a brief lull, adding to mounting evidence of an acceleration in the U.S. economy despite a series of strains.
StockMarketWatch
Here’s the most you should be spending on your car payment, whether you make $60,000 or over $150,000
For car buyers today, saving over a few years for a large down payment can be critical to reducing the amount they borrow and the length of their loan
StockMarketWatch
U.S. inflation rises again and keeps the pressure on Fed
The main inflation gauge used by the Federal Reserve to set U.S. interest rates rose sharply in August, underscoring why the central bank raised interest rates earlier this month for the first time in three years.
StockMarketWatch
Meta is pitching a bold new identity — and the payoff could be big
Enterprise tools present a compelling business opportunity as Facebook and Instagram parent Meta looks to diversify its revenue away from advertising.
StockMarketWatch
‘I’m afraid of human stupidity.’ Why this top economist prefers U.S. tech and gold over bonds.
A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently about government debt.
StockMarketWatch
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
StockMarketWatch
Boeing was at risk of losing all fighter-jet production altogether. Now the stock is up on a new Navy contract.
Shares in the aerospace company rose close to 3% in premarket trading on Wednesday after the U.S. Navy selected it to develop its next-generation fighter jet.
News text belongs to its source; only the headline and a short summary appear here.